235 related articles for article (PubMed ID: 1729263)
21. Apoptosis in breast cancer as related to histopathological characteristics and prognosis.
Lipponen P; Aaltomaa S; Kosma VM; Syrjänen K
Eur J Cancer; 1994; 30A(14):2068-73. PubMed ID: 7857705
[TBL] [Abstract][Full Text] [Related]
22. The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer.
Jobsen JJ; van der Palen J; Brinkhuis M; Nortier JW; Struikmans H
Breast Cancer Res Treat; 2015 Jan; 149(2):343-51. PubMed ID: 25526926
[TBL] [Abstract][Full Text] [Related]
23. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
24. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
[TBL] [Abstract][Full Text] [Related]
25. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium.
Jannink I; van Diest PJ; Baak JP
Hum Pathol; 1995 Oct; 26(10):1086-92. PubMed ID: 7557941
[TBL] [Abstract][Full Text] [Related]
27. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
28. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
29. The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Cancer Res Clin Oncol; 1996; 122(11):687-92. PubMed ID: 8898980
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 protein has no independent prognostic value in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
[TBL] [Abstract][Full Text] [Related]
31. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
Clayton F; Hopkins CL
Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
[TBL] [Abstract][Full Text] [Related]
32. Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material.
Ikpatt OF; Kuopio T; Collan Y
Mod Pathol; 2002 Aug; 15(8):783-9. PubMed ID: 12181262
[TBL] [Abstract][Full Text] [Related]
33. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
34. Hormone receptors as prognostic factors in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Ann Med; 1991 Dec; 23(6):643-8. PubMed ID: 1777219
[TBL] [Abstract][Full Text] [Related]
35. Prediction of the axillary lymph node status in mammary cancer on the basis of clinicopathological data and flow cytometry.
Mattfeldt T; Kestler HA; Sinn HP
Med Biol Eng Comput; 2004 Nov; 42(6):733-9. PubMed ID: 15587463
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
37. The prognosis of small primary breast cancers.
Kollias J; Murphy CA; Elston CW; Ellis IO; Robertson JF; Blamey RW
Eur J Cancer; 1999 Jun; 35(6):908-12. PubMed ID: 10533470
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte infiltrates as a prognostic variable in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Eur J Cancer; 1992; 28A(4-5):859-64. PubMed ID: 1524909
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors after 5 years follow-up in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Oncology; 1992; 49(2):93-8. PubMed ID: 1574258
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of factors influencing the axillary lymph node metastasis and breast cancer-specific survival in patients with T1 breast cancer].
Jiao DC; Qiao JH; Zhu JJ; Wang LN; Ma YZ; Lu ZD; Liu ZZ
Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3258-3262. PubMed ID: 30392292
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
